• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性唇疱疹:病毒复制与临床病程。

Recurrent herpes simplex labialis: viral replication and clinical course.

作者信息

Rytel M W, Niebojewski R A, Aguilar-Torres F G, Russell T J

出版信息

Am J Med Sci. 1978 Nov-Dec;276(3):319-23. doi: 10.1097/00000441-197811000-00009.

DOI:10.1097/00000441-197811000-00009
PMID:217269
Abstract

The purpose of this study was to provide additional information on the clinical course and viral replication kinetics of herpes simplex virus (HSV) in recurrent herpes labialis. Data were obtained on 20 subjects who were followed for five days from the first day of the lesion. HSV was isolated in 17 subjects (85%); 75% were positive on day 1 of the lesion. Median HSV titer on day 1 was 1.7 x 10(3)/0.2ml. Isolation rates and titers dropped sharply and virus could no longer be detected by day 4. The clinical course both in terms of the frequency and the severity of the symptoms paralleled the kinetics of viral replication. Thermography delineated location of subsequent lesions in three early symptomatic patients who were studied at the time when no visible lesions were observed. These data are felt to provide useful background information for future studies on the efficacy of topical antiviral agents.

摘要

本研究的目的是提供关于复发性唇疱疹中单纯疱疹病毒(HSV)临床病程及病毒复制动力学的更多信息。对20名受试者从病损第一天起进行了为期五天的随访,并获取了相关数据。17名受试者(85%)分离出了HSV;病损第一天75%呈阳性。病损第一天HSV滴度中位数为1.7×10³/0.2ml。分离率和滴度急剧下降,到第4天就再也检测不到病毒了。症状的频率和严重程度方面的临床病程与病毒复制动力学情况相似。热成像描绘了三名早期有症状患者在未观察到可见病损时后续病损的位置。这些数据被认为可为今后局部抗病毒药物疗效研究提供有用的背景信息。

相似文献

1
Recurrent herpes simplex labialis: viral replication and clinical course.复发性唇疱疹:病毒复制与临床病程。
Am J Med Sci. 1978 Nov-Dec;276(3):319-23. doi: 10.1097/00000441-197811000-00009.
2
The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.复发性唇疱疹的自然病程:对抗病毒治疗的启示。
N Engl J Med. 1977 Jul 14;297(2):69-75. doi: 10.1056/NEJM197707142970201.
3
[The virological diagnosis of recurrent labial herpes].[复发性唇疱疹的病毒学诊断]
Stomatologiia (Mosk). 1991 Nov-Dec(6):22-3.
4
The natural history of recurrent facial-oral infection with herpes simplex virus.
J Infect Dis. 1978 Dec;138(6):897-905. doi: 10.1093/infdis/138.6.897.
5
Detection of herpes simplex virus DNA in the peripheral blood during acute recurrent herpes labialis.复发性唇疱疹急性期外周血单纯疱疹病毒DNA的检测
J Am Acad Dermatol. 1992 Apr;26(4):594-8. doi: 10.1016/0190-9622(92)70087-v.
6
Pathogenesis of recurrent herpes simplex labialis. IV. Maturation of lesions within 8 hours after onset and implications for antiviral treatment.
Oral Surg Oral Med Oral Pathol. 1984 Dec;58(6):667-71. doi: 10.1016/0030-4220(84)90031-8.
7
Correlation between detection of herpes simplex virus in oral secretions by PCR and susceptibility to experimental UV radiation-induced herpes labialis.通过聚合酶链反应检测口腔分泌物中单纯疱疹病毒与实验性紫外线诱导唇疱疹易感性之间的相关性
J Clin Microbiol. 1994 Dec;32(12):3088-90. doi: 10.1128/jcm.32.12.3088-3090.1994.
8
Immunostimulatory function of herpes simplex virus isolates from patients with frequent herpes labialis and a deficiency in immune-specific interferon production.
J Med Virol. 1985 Jul;16(3):289-96. doi: 10.1002/jmv.1890160310.
9
Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavity.唇疱疹的发病机制:病毒在口腔中的排泄。
J Clin Microbiol. 1984 May;19(5):675-9. doi: 10.1128/jcm.19.5.675-679.1984.
10
Viral-induced leukocyte interferon in vesicle fluid from lesions of recurrent herpes labialis.
J Infect Dis. 1981 Apr;143(4):543-7. doi: 10.1093/infdis/143.4.543.

引用本文的文献

1
Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.新型综合疗效指标用于证明复发性唇疱疹抗病毒-抗炎联合治疗的原理及疗效。
Antimicrob Agents Chemother. 2014;58(3):1273-8. doi: 10.1128/AAC.02150-13. Epub 2013 Dec 16.